Skip to main content
. 2021 Jun 16;14(6):e012459. doi: 10.1161/CIRCIMAGING.121.012459

Figure 5.

Figure 5.

The role of normal myocardium (%) in the diagnostic evaluation of cancer patients. A, Additional diagnostic window provided by normal myocardium (%) versus left ventricular (LV) ejection fraction for the prediction of clinical cardiotoxicity (CTX) and for its early identification, allowing monitoring of cardiac safety during chemotherapy. B, Proposed clinical algorithm incorporating clinical and cardiovascular magnetic resonance (CMR) data for the management of patients who undergo chemotherapy. CAD indicates coronary artery disease; REC, recovery from cardiotoxicity; and ROC, recovery from cardiotoxicity.